Brand CEO Alan Green talks Angus Energy (ANGS), Feedback (FDBK), Advanced Onco (AVO) & Swallowfield (SWL) on the VOX Markets podcast
Brand CEO Alan Green talks Angus Energy (ANGS), Feedback (FDBK), Advanced Onco (AVO) & Swallowfield (SWL) with Justin Waite on the VOX Markets podcast. Interview starts at 46 minutes 20 seconds.
Feedback (FDBK) – Re Media Articles
Feedback plc (AIM: FDBK), the medical imaging software company, is pleased to update shareholders following the recent media articles regarding the use of multi-parametric MRI scans for the diagnosis of prostate cancer. It was widely reported in the national press and on the BBC website on 20 January 2017 that a trial led by Mr […]
Feedback (FDBK): Above 50 day line points as high as 5p – Master Investor
by Zak Mir It appeared that for a while there was a degree of negative sentiment associated with medical imaging group Feedback (LON:FDBK), but the background noise now looks to have finally cleared, so to speak. It can be seen from the daily chart of Feedback that we are finally back on the front foot, […]
Malcolm Stacey, ShareProphets – Tom no likey this medical pioneer. But I do…
Hello Share Rattlers. Quite a few of my friends face a grim Christmas. They are undergoing radio and chemo treatment for cancer. Is it me, or is the number of cases growing even faster than normal? I am invested in a few companies that are fighting this scourge. One such outfit is Feedback (FDBK). This […]
Texture Analysis on Computed Tomography Predicts the Outcome of Patients with Hodgkin Lymphoma – Feedback Plc (FDBK)
Background Texture analysis is a novel approach, which analyses the distribution of pixel on computed tomography (CT) within a region of interest. CT-based texture analysis (CTTA) can be applied to images that are acquired in routine clinical practice and provide prognostic information in patients with non-small cell lung cancer or colorectal adenocarcinoma. We aimed to […]
Daily Mail – SMALL CAP IDEAS: Feedback’s new chairman reveals pioneering cancer imaging program is proving a hit
From Daily Mail by Ian Lyall at Proactive Investors for ThisIsMoney Dr Alastair Riddell’s CV reveals a high-flying career with the forerunners of what are now GE Healthcare, Johnson & Johnson and Pfizer, followed by spells guiding businesses to IPO or trade sale. So, what attracted him to the challenge of Feedback, the Cambridge-based AIM-listed […]
TexRAD presenting 19 papers at RSNA 2016 – Feedback (FDBK)
TexRAD is attending the 102nd scientific assembly and annual meeting of the Radiological Society of North America, running from the 27th November to 2nd December 2016 at the McCormick Place in Chicago, USA. This year at the RSNA there will be around 19 presentations (5 of which have won student awards) from our customer sites spread across USA, […]
Feedback chairman says cancer software has ‘real potential’ – Proactive Investors
By Ian Lyall – Proactive Investors Distilled down to the basics, the company’s TexRAD technology is essentially a very smart piece of software that analyses medical images, to reveal features that are not always evident to the human eye. Dr Alastair Riddell’s CV reveals a high-flying career with the forerunners of what are now GE […]
‘Undoubtedly an exciting time for Texrad’ says Feedback Chairman – ProactiveInvestors Stocktube
Feedback plc (FDBK) chairman Alastair Riddell caught up with Proactive’s Andrew Scott to discuss their latest results and outlook for the company.
Feedback PLC (FDBK) – Attendance at RSNA 2016
Feedback plc (AIM: FDBK), the medical imaging software company, is pleased to provide an update on the Company’s attendance at the 102nd Scientific Assembly and Annual Meeting of the Radiological Society of North America to be held 27 November – 2 December 2016, in Chicago, Illinois, USA. (“RSNA 2016”). This is the premier global event for […]